Study guide
1.1 BCEMP Exam Logistics, Content Outlines & Scoring
BCEMP Board Certified Emergency Medicine Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction, Triage, and Resuscitation Fundamentals
1.1 BCEMP Exam Logistics, Content Outlines & Scoring 1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination 1.3 Resuscitation Pharmacology, Pharmacokinetics & Vascular Access
2 Chapter 2: Cardiac Arrest and Dysrhythmias
2.1 Adult Cardiac Arrest & ACLS Pharmacotherapy Protocols 2.2 Acute Tachyarrhythmias: Narrow- and Wide-Complex Management 2.3 Symptomatic Bradycardia & Vasoactive Chronotropic Support 2.4 Post-Cardiac Arrest Care & Targeted Temperature Management (TTM)
3 Chapter 3: Shock and Hemodynamic Resuscitation
3.1 Sepsis & Septic Shock: Surviving Sepsis Campaign 2026 Resuscitation 3.2 Cardiogenic & Obstructive Shock, Mechanical Circulatory Support & LVADs 3.3 Hypovolemic & Hemorrhagic Shock Fluid Protocols
4 Chapter 4: Airway Management and Rapid Sequence Intubation (RSI)
4.1 Rapid Sequence Intubation (RSI) Process & Pretreatment Agents 4.2 RSI Induction Agents: Pharmacology, Selection & Dosing 4.3 Neuromuscular Blocking Agents & Post-Intubation Analgosedation
5 Chapter 5: Neurocritical Care and Neurologic Emergencies
5.1 Acute Ischemic Stroke: Thrombolysis & Blood Pressure Control 5.2 Intracranial Hemorrhage & Elevated ICP Pharmacotherapy 5.3 Status Epilepticus: Tiered Emergent Anticonvulsant Therapy 5.4 Traumatic Brain Injury & Spinal Cord Emergencies
6 Chapter 6: Acute Coronary Syndromes and Acute Heart Failure
6.1 Acute Coronary Syndromes: STEMI & NSTE-ACS Pharmacotherapy 6.2 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 6.3 Hypertensive Crises: Emergencies, Urgencies & Target Blood Pressure
7 Chapter 7: Pulmonary and Allergic Emergencies
7.1 Acute Pulmonary Embolism: Risk Stratification & Thrombolytic Therapy 7.2 Severe Asthma Exacerbation & COPD Acute Management 7.3 Anaphylaxis & Severe Allergic Reactions: Acute Epinephrine Protocols
8 Chapter 8: Clinical Toxicology: Approach to Poisoning and Common Overdoses
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination 8.2 Acetaminophen Overdose & N-Acetylcysteine Dosing Strategies 8.3 Salicylate Toxicity & Toxic Alcohol Management (Fomepizole) 8.4 Opioid Toxicity & Sedative-Hypnotic/Alcohol Withdrawal Syndromes 8.5 Beta-Blocker & Calcium Channel Blocker Toxicity (HIET, Calcium, Glucagon)
9 Chapter 9: Toxicology: Specialized Poisonings and Antidotes
9.1 Digoxin, Tricyclic Antidepressants & Anticholinergic Toxicity 9.2 Cyanide, Carbon Monoxide & Organophosphate/Cholinergic Toxins 9.3 Snake and Spider Envenomations & Heavy Metal Chelation 9.4 Additional Antidotes: Methemoglobinemia, Isoniazid, Sulfonylureas, Valproate, Sympathomimetics & LAST
10 Chapter 10: Hemostasis, Anticoagulant Reversal, and Hematology
10.1 DOAC & Warfarin Reversal: Specific Reversal Agents & 4F-PCC 10.2 Heparin-Induced Thrombocytopenia (HIT) & Direct Thrombin Inhibitors 10.3 Sickle Cell Vaso-Occlusive Crises & Acute Chest Syndrome
11 Chapter 11: Endocrine, Electrolyte, and Metabolic Emergencies
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Severe Electrolyte Emergencies: Hyperkalemia & Hyponatremia 11.3 Endocrine Crises: Thyroid Storm, Myxedema Coma & Acute Adrenal Crisis 11.4 Acute Kidney Injury, Dialyzability & Drug Dosing during RRT
12 Chapter 12: Infectious Diseases and Antimicrobial Stewardship
12.1 Severe Community & Hospital-Acquired Infections in the ED 12.2 Skin & Soft Tissue, STI, and Vector-Borne Emergencies 12.3 ED Antimicrobial Stewardship & Rapid Microbiologic Diagnostics
13 Chapter 13: Special Populations: Pediatrics, Trauma, and Obstetrics
13.1 Pediatric Resuscitation, Status Epilepticus & PALS Pharmacotherapy 13.2 Trauma Pharmacotherapy: Massive Transfusion, TXA, Open Fractures, Tetanus & Burns 13.3 Obstetric & Gynecologic Emergencies: Preeclampsia, Eclampsia & PPH
14 Chapter 14: Medication Safety, ED Operations, and Disaster Preparedness
14.1 ED High-Alert Medications, Error Reporting & Technology Safeguards 14.2 ED Workflow, Transitions of Care & Boarding Patient Management 14.3 Mass Casualty Incidents, CBRNE Countermeasures & Strategic Stockpiles
15 Chapter 15: Biostatistics, Study Design, and Literature Evaluation
15.1 Biostatistics & Hypothesis Testing: Power, Errors & Interpretations 15.2 Clinical Study Designs & Measures of Effect 15.3 Literature Evaluation, Clinical Guidelines & Research Conduct in the ED
16 Chapter 16: Medical Devices, Ventilation, and Medication Delivery
16.1 Mechanical Ventilation, Noninvasive Ventilation & High-Flow Oxygen: What the Pharmacist Must Know 16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management 16.3 Infusion Pumps, Patient-Owned Devices & Medication Delivery Device Counseling
17 Chapter 17: Organ-System Emergencies: GI, GU, Oncology, Neurology, ENT, Pain, and Psychiatry
17.1 Gastrointestinal & Hepatic Emergencies: GI Bleeding, Cirrhosis Complications, Pancreatitis & Vomiting 17.2 Genitourinary Emergencies: UTI & Pyelonephritis, Renal Colic, Urinary Retention, Priapism & Scrotal Infections 17.3 Oncologic, Immunotherapy & Hematologic Emergencies: Febrile Neutropenia, TLS, Hypercalcemia, irAEs, CAR-T, Hemophilia & TTP 17.4 Headache & Neuromuscular Emergencies: Migraine, Cluster, Myasthenic Crisis, Guillain-Barré & Bell's Palsy 17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain 17.6 Acute Pain Management & Procedural Sedation and Analgesia in the ED 17.7 Psychiatric Emergencies: Severe Agitation, Serotonin Syndrome, NMS, Lithium Toxicity & Psychotropic Overdose
18 Chapter 18: Special Populations, Medication Access, and Professional Practice
18.1 Pharmacogenomics, Adverse Drug Events & High-Risk Drug Interactions in Emergency Care 18.2 Special Populations: Older Adults, Extremes of Weight, Pregnancy & Lactation, and Immunocompromised Patients 18.3 Social Determinants of Health, Health Literacy & Medication Access at ED Discharge 18.4 Healthcare Regulations & Standards: FDA, REMS, Bar Coding, DEA, CMS, EMTALA, The Joint Commission, NIOSH & USP 18.5 Formulary & Inventory Management, Drug Shortages, Antidote Stocking & Clinical Decision Support 18.6 Quality Improvement, Practice Standards & Interprofessional Collaboration (Protocols, Teamwork & Debriefing)
1.1 BCEMP Exam Logistics, Content Outlines & Scoring
Key Takeaways Explain This Topic AI
The BCEMP exam has 150 multiple-choice items (125 scored, 25 unscored pretest items) delivered in 3 hours 45 minutes at Pearson VUE test centers.
BPS reports a scaled score from 200 to 800, and 500 is the passing point; passing candidates receive no numeric score.
Exams given through November 30, 2026 use the 2024 content outline (Patient Care 75%, Practice Management 15%, Education and Research 10%).
Exams given on or after December 1, 2026 use the 2025 outline: Emergency Medicine 17%, Therapeutics and Patient Management 66%, Professional Practice 17%.
The first-time application fee is $600 and the retake fee is $300, with three attempts in total and a 90-day wait after each attempt.
Last updated: October 2026
Note
Independent BCEMP study resource provided by ExamFinch. Exam facts below come from the Board of Pharmacy Specialties (BPS) Emergency Medicine Pharmacy page, the 2024 and 2025 BCEMP Examination Specifications, the BPS Candidate's Guide and BPS results announcements, checked on 2026-10-01.
The Credential
The Board-Certified Emergency Medicine Pharmacist (BCEMP) credential is awarded by the Board of Pharmacy Specialties (BPS) . BPS formally recognized emergency medicine pharmacy as its fourteenth specialty in February 2020 , and the first BCEMP examination window ran in April–May 2023 . BPS describes the target population as pharmacists who provide and support patient care at the bedside in emergency medicine settings, and it reported more than 930 BCEMP-certified pharmacists in 2026.
The exam rewards practical bedside judgment: choosing a drug, dose, route and monitoring plan for a patient who is deteriorating, often with incomplete information. The BPS sample items show the style — a pediatric SVT dose of adenosine, a drug-induced hyponatremia, an inferior STEMI where nitrates are dangerous, a ketamine analgesia monitoring policy, autoinjector counseling for a child and parent, and a thrombolytic contraindication.
Examination Format
- Feature BCEMP rule
- Items 150 multiple-choice items: 125 scored and 25 unscored pretest items mixed in
- Time 3 hours 45 minutes, including the introduction and tutorial
Delivery Pearson VUE test centers; online/remote testing only by case-by-case BPS approval (US, Australia, Canada)
- Breaks No scheduled break. One optional 10-minute unscheduled break; the clock keeps running
- Navigation Items must be answered in the order presented; you cannot return to earlier items or skip ahead
- Calculator On-screen scientific calculator
Item types Mostly single-best-answer from four options; a small share may ask for several answers from up to eight options, and some include an image
At 225 minutes for 150 items you have 90 seconds per item . Because you cannot go back, flagging and returning is not a strategy: commit to your best answer, keep moving and budget time for long vignettes.
Two Content Outlines Around December 1, 2026
BPS runs a job analysis about every five years. Its content-outline page lists two BCEMP outlines : the 2024 specifications apply to administrations through November 30, 2026 , and the 2025 specifications apply from December 1, 2026 . Check your appointment date before you plan your study.
2024 Outline (exams through November 30, 2026)
Domain Weight What it tests
1. Patient Care/Management 75% Bedside management of emergencies and resuscitations, triage, history taking, medication-related problems, care plans, time-sensitive therapy, alternative routes, monitoring, drug information and transitions of care (tasks 1.01–1.13)
2. Practice Management 15% Adverse drug events, quality assurance, inventory, order review, regulatory compliance, shortages, disaster planning, guidelines, practice advancement and committee work (tasks 2.01–2.11)
3. Education and Research 10% Teaching, patient and caregiver education, professional development, literature evaluation and research (tasks 3.01–3.05)
2025 Outline (exams from December 1, 2026)
- Domain Weight Subdomains (weight)
- 1. Emergency Medicine 17% 1A Emergency Medicine Operations (8%); 1B Medical Therapies and Devices (9%)
2. Therapeutics and Patient Management 66% 2A Patient Assessment (13%); 2B Pharmacotherapy (33%); 2C Therapeutic Implementation, Outcomes, and Monitoring (20%)
3. Professional Practice 17% 3A Quality of Care (9%); 3B Practice Management (8%)
The 2025 outline lists 50 subtopics. Examples include pre-hospital care and poison centers (1A); ventilation, mechanical circulatory support, renal replacement therapy, lines, infusion devices and delivery devices (1B); pharmacotherapy from cardiology through trauma and burns (2B); monitoring, adverse drug events, transitions of care and counseling (2C); and medication safety, regulations, formulary and shortage management, informatics, biostatistics, literature evaluation and disaster management (3).
This guide follows the 2025 subtopics. Chapters 16–18 cover the devices, systems pharmacotherapy and professional-practice subtopics, and the older 2024 task list is covered by the same material.
Eligibility
Both specifications require all three of the following:
Graduation from an ACPE-accredited pharmacy program, or a program outside the US that qualifies you to practice in your jurisdiction.
A current, active pharmacist license or registration in the US or another jurisdiction.
One of these, completed within the past 7 years:
At least 4 years of emergency medicine pharmacy practice after licensure, with at least 50% of time in the scope of the content outline;
A PGY1 residency plus at least 2 years of such practice after licensure; or
A PGY2 residency in emergency medicine pharmacy .
Practice-pathway applicants need an attestation from their employer, on company letterhead, that the experience represents at least 50% of their time in the outline's activities. Residencies must be ASHP-accredited or in candidate status (or CPRB-accredited year-1 programs).
Scheduling, Scoring and Results
Continuous testing : BCEMP is offered year-round. For authorizations to test issued after January 1, 2026, you have 90 days to sit; missing the window counts as a no-show and forfeits fees.
Scaled scoring : BPS equates test forms and reports scores on a 200–800 scale with 500 as the passing point . The passing standard is set by criterion-referenced procedures; there is no fixed percentage and no curve.
Results : since January 2026 candidates see a preliminary pass or fail on screen, and the official score report appears in MyBPS within 45 days. Passing candidates get no numeric score. Failing candidates see their total score and high/moderate/low domain feedback.
No guessing penalty : unanswered items are simply wrong, so answer everything.
Pass-Rate History (BPS announcements)
- Administration All candidates First-time candidates
- Apr–May 2023 (first window) 72% (439 examinees) 72%
- Aug–Sep 2023 54% 59%
- Mar–Apr 2024 60% 62%
- Sep–Oct 2024 50% 55%
- 2025 continuous testing 53.9% (323 examinees) 61.1% (198 examinees)
- Fees, Retakes and Recertification
- Item 2026 amount or rule
- Initial application $600
- Retake application $300
- Attempts 3 in total (initial plus 2 retakes); 90-day wait after each attempt, then 90 days to test
- After a third failure Wait 12 months, then reapply at $600
- Reschedule or cancel Free 30 or more days ahead; $60 at 5–29 days; not allowed under 5 days
- Annual maintenance fee $125 in years 1–6
- Recertification fee $400 in year 7
Certification runs on a 7-year cycle , and you must report at least 2 units of assessed continuing education or self-reported professional development every year. You recertify by either route:
Professional development program : 100 units, made up of at least 80 units of assessed continuing pharmacy education from BPS-approved programs (ASHP with ACCP) and up to 20 units of self-reported continuing professional development; or
Recertification exam : pass the exam and report 20 units of continuing professional development. BPS says BCEMP recertification exams begin in 2030, when the first cohort reaches year 7.
Tip
About two-thirds of the newer outline is pharmacotherapy and monitoring, but the remaining third is not optional. Operations, devices, safety, regulations and biostatistics are high-yield because many candidates under-prepare them.